Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


27.02.2017

2 Am J Hematol
1 Ann Hematol
2 Blood
1 BMJ
1 Bone Marrow Transplant
2 Cancer
2 Eur J Haematol
1 Int J Hematol
1 J Clin Oncol
2 Leuk Res
4 Leukemia
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. KAYA Z, Alici N, Ozmen OE, Akgul M, et al
    Identification of renal infiltration based on urinary findings in a child with burkitt leukemia/lymphoma.
    Am J Hematol. 2017 Feb 22. doi: 10.1002/ajh.24694.
    PubMed     Text format    

  2. DE MARCHI F, Candoni A, Zannier ME, Lau WY, et al
    Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD Acute Myeloid Leukemia patients: which should we trust as a minimal residual disease marker?
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24686.
    PubMed     Text format    


    Ann Hematol

  3. JUD S, Goede JS, Senn O, Spanaus K, et al
    sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-alpha therapy.
    Ann Hematol. 2017 Feb 18. doi: 10.1007/s00277-017-2943.
    PubMed     Text format     Abstract available


    Blood

  4. YOSHIZATO T, Nannya Y, Atsuta Y, Shiozawa Y, et al
    Impact of genetic alterations in stem-cell transplantation for myelodysplasia and secondary acute myeloid leukemia.
    Blood. 2017 Feb 21. pii: blood-2016-12-754796. doi: 10.1182/blood-2016-12-754796
    PubMed     Text format     Abstract available

  5. NAKATA Y, Ueda T, Nagamachi A, Yamasaki N, et al
    Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.
    Blood. 2017 Feb 16. pii: blood-2016-06-724658. doi: 10.1182/blood-2016-06-724658
    PubMed     Text format     Abstract available


    BMJ

  6. JOPPI R, Gerardi C, Bertele' V, Garattini S, et al
    Letting post-marketing bridge the evidence gap: the case of orphan drugs.
    BMJ. 2016;353:i2978.
    PubMed     Text format    


    Bone Marrow Transplant

  7. O'HARE P, Lucchini G, Cummins M, Veys P, et al
    Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    Cancer

  8. QU X, Othus M, Davison J, Wu Y, et al
    Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
    Cancer. 2017 Feb 21. doi: 10.1002/cncr.30626.
    PubMed     Text format     Abstract available

  9. PAVLU J, Labopin M, Zoellner AK, Sakellari I, et al
    Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
    Cancer. 2017 Feb 17. doi: 10.1002/cncr.30604.
    PubMed     Text format     Abstract available


    Eur J Haematol

  10. AL-SAWAF O, Fischer K, Herling CD, Ritgen M, et al
    Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
    Eur J Haematol. 2017;98:254-262.
    PubMed     Text format     Abstract available

  11. NOLTE F, Mossner M, Jann JC, Nowak D, et al
    Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
    Eur J Haematol. 2017;98:302-310.
    PubMed     Text format     Abstract available


    Int J Hematol

  12. MOLTENI A, Riva M, Ravano E, Marbello L, et al
    Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
    Int J Hematol. 2017 Feb 20. doi: 10.1007/s12185-017-2198.
    PubMed     Text format     Abstract available


    J Clin Oncol

  13. THOMAS X, de Botton S, Chevret S, Caillot D, et al
    Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission.
    J Clin Oncol. 2017 Feb 21:JCO2016704551. doi: 10.1200/JCO.2016.70.4551.
    PubMed     Text format     Abstract available


    Leuk Res

  14. KANG KW, Kim DS, Lee SR, Sung HJ, et al
    Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.
    Leuk Res. 2017;57:1-8.
    PubMed     Text format     Abstract available

  15. PULTE D, Castro FA, Brenner H, Jansen L, et al
    Outcome disparities by insurance type for patients with acute myeloblastic leukemia.
    Leuk Res. 2017;56:75-81.
    PubMed     Text format     Abstract available


    Leukemia

  16. HOCHHAUS A, Masszi T, Giles FJ, Radich JP, et al
    Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the ENESTfreedom study.
    Leukemia. 2017 Feb 20. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  17. SHIMA Y, Yumoto M, Katsumoto T, Kitabayashi I, et al
    MLL is essential for NUP98-HOXA9-induced leukemia.
    Leukemia. 2017 Feb 17. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  18. KOBAYASHI M, Chen S, Bai Y, Yao C, et al
    Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia.
    Leukemia. 2017 Feb 21. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  19. SUGINO N, Kawahara M, Tatsumi G, Kanai A, et al
    A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers.
    Leukemia. 2017 Feb 17. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  20. SJOBERG M, Loving R, Lindqvist B, Garoff H, et al
    Sequential activation of the three protomers in the Moloney murine leukemia virus Env.
    Proc Natl Acad Sci U S A. 2017 Feb 21. pii: 201617264.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: